期刊文献+

我国轮状病毒的流行及免疫预防 被引量:16

Rotavirus prevalence and rotavirus vaccine in China
原文传递
导出
摘要 轮状病毒是5岁以下儿童重症腹泻的首要病原,每个5岁以下儿童均会感染,轮状病毒疫苗是预防轮状病毒腹泻的最有效手段。我国轮状病毒腹泻的疾病负担具有发病率低、检出率高、死亡率低但死亡例数高、经济负担沉重的特点。目前我国轮状病毒监测网络对轮状病毒的疾病负担、毒株监测及疫苗的评价效果较好,但对于轮状病毒死亡估计的本土数据利用不足且缺乏轮状病毒疫苗安全性监测的专门网络。我国上市的两个轮状病毒疫苗属于非免疫规划疫苗,效果及安全性良好,但实际使用中存在不同的问题。世界卫生组织建议所有国家将轮状病毒疫苗纳入国家免疫规划,希望我国在将轮状病毒疫苗纳入国家免疫规划之前能做好数据和技术的储备以支持决策。 Rotavirus is the major pathogen causing severe diarrhea among children under 5 years of age. Rotavirus vaccine has been proved to be the most effective method in rotavirus prevention and control. The prevalence of rotavirus in China is characterized by low morbidity,high positivity,low mortality but high number of deaths and high economic burden. Rotavirus surveillance network in China has achieved crucial effect in the evaluation of rotavirus disease burden,strain surveillance and evaluation of rotavirus vaccine effectiveness. However,estimation of rotavirus deaths with local data is not enough. Furthermore,no surveillance network of the safety monitoring of rotavirus vaccine has been established. The two licensed rotavirus vaccines in China,which are not included in the national immunization program,demonstrate very good effectiveness and safety,but there are still issues to be discussed in vaccination practice. WHO recommended all countries include rotavirus vaccine into national immunization program,and before that we should get prepared in data and techniques for its implementation in China.
作者 刘娜 LIU Na(National Institute for Viral Disease Control and Prevention,China CDC,Beijing 102206,China)
出处 《中国实用儿科杂志》 CSCD 北大核心 2021年第5期328-331,共4页 Chinese Journal of Practical Pediatrics
关键词 轮状病毒 疾病负担 监测 疫苗 rotavirus disease burden surveillance vaccine
  • 相关文献

参考文献3

二级参考文献17

  • 1何斌,杨建洲,秦兰岚,韩晖.海淀田村地区第二类疫苗接种情况分析[J].中国医药指南,2008,6(20). 被引量:24
  • 2卫生部公布2009年1月及2008年度全国法定报告传染病疫情[J].中华人民共和国卫生部公报,2009(3):65-68. 被引量:10
  • 3方琼,王永刚,黄慧萍,等.深圳市福田区2007年疫苗使用情况调查分析[J].基础医学论坛,2008,12(9月上旬刊):858-860. 被引量:2
  • 4Murphy TV,Gargiullo PM,Massoudi MS. Intussusception among infants given an oral rotavirus vaccine[J].New England Journal of Medicine,2001.564-572.doi:10.1056/NEJM200102223440804. 被引量:1
  • 5Ruiz-Palacios GM,Perez-Schael I,Velazquez FR. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis[J].New England Journal of Medicine,2006.11-22.doi:10.1056/NEJMoa052434. 被引量:1
  • 6Vesikari T,Matson DO,Dennehy P. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine[J].New England Journal of Medicine,2006.23-33.doi:10.1056/NEJMoa052664. 被引量:1
  • 7Yesikari T,Karvonen A,Forrest BD. Neonatal administration of rhesus rotavirus tetravalent vaccine[J].Pediatric Infectious Disease Journal,2006.118-122. 被引量:1
  • 8Gladstone BP,Ramani S,Mukhopadhya I. Protective effect of natural rotavirus infection in an Indian birth cohort[J].New England Journal of Medicine,2011.337-346. 被引量:1
  • 9Duan ZJ,Liu N,Yang SH. Hospital-Based Surveillance of Rotavirus Diarrhea in the People's Republic of China,August 2003-July 2007[J].Journal of Infectious Diseases,2009,(Suppl 1):S167-S173. 被引量:1
  • 10Zaman K,Sack DA,Yunus M. Successful coadministration of a human rotavirus and oral poliovirus vaccines in Bangladeshi infants in a 2-dose schedule at 12 and 16 weeks of age[J].Vaccine,2009,(9):1333-1339.doi:10.1016/j.vaccine.2008.12.059. 被引量:1

共引文献166

同被引文献163

引证文献16

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部